69 Fabry Disease 70 Facioscapulohumeral Muscular Dystrophy 71 Factor XI Deficiency 72 Factor XIII Deficiency 73 Familial Adenomatous Polyposis

Size: px
Start display at page:

Download "69 Fabry Disease 70 Facioscapulohumeral Muscular Dystrophy 71 Factor XI Deficiency 72 Factor XIII Deficiency 73 Familial Adenomatous Polyposis"

Transcription

1 GENE TEST GENE TEST 69 Fabry Disease GLA Fabry disease Cardiac Variant Fabry Disease Classic Fabry Disease 70 Facioscapulohumeral Muscular Dystrophy D4Z4 (LOCUS) facioscapulohumeral muscular dystrophy 71 Factor XI Deficiency F11 factor XI deficiency XI 72 Factor XIII Deficiency F13A1 factor XIIIA deficiency XIIIA 73 Familial Adenomatous Polyposis APC familial ademomatous polyposis Attenuated Adenomatous Polyposis Coli [Attenuated FAP] Gardner syndrome Gardner Syndrome Adenomatous Polyposis Coli with CNS Tumors [Turcot Syndrome] 255 Familial Atypical Mycobacteriosis IFNGR1 IFNGR2 IL12B (ILP40) IL12RB1 Familial atypical mycobacteriosis 74 Familial Cavernous Hemangioma [Familial Cerebral Cavernous Malformation] CCM1 familial cavenous angioma Familial Cerebral Cavernous Malformation 1 75 Familial Dysautonomia [Riley-Day Syndrome] IKBKAP Riley-Day syndrome 76 Familial Essential Tremor [Hereditary Essential Tremor] ETM1,ETM2 familial essensial tremor 77 Familial Hemiplegic Migraine familial migraine Familial Hemiplegic Migraine 1 Familial Hemiplegic Migraine 2 CACNL1A4 ATP1A2 252 Familial Hibernian Fever TNFRSF1A TNFalpha receptor 1 associated periodic fever syndrome(traps) 78 Familial Hypercholesterolemias HYPERCHOLESTEROLEMIA, FAMILIAL Familial Hypercholesterolemia Familial Hypercholesterolemia Type B LDLR APOB 79 Familial Hyperinsulinism HYPERINSULINISM-HYPERAMMONEMIA SYNDROME - ABCC8-Related Hyperinsulinism GCK-Related Hyperinsulinism Hyperinsulinism-Hyperammonemia Syndrome [GLUD1-Related Hyperinsulinism] KCNJ11-Related Hyperinsulinism ABCC8 GCK GLUD1 KCNJ11 80 Familial Hypertrophic Cardiomyopathy MYH7,TNNT2,TPM1,MYBPC3,TNNI3,MYL3,MYL2,ACTC Hypertrophic Cardiomyopathy 81 Familial Hypocalciuric Hypercalcemia, Type I CASR HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I Ca Ca 82 Familial Mediterranean Fever MEFV Familial Mediterranean fever Familial Mediterranean Fever Type 1 Familial Mediterranean Fever Type 2 83 Familial Myxoma [Carney Complex] PRKAR1A atrial myxoma, familial 84 Familial Neuroblastoma NB familial neuroblastoma 85 Familial Non-Autoimmune Hyperthyroidism TSHR HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT 86 Fanconi Anemia Fanconi anemia BRCA2-Related Fanconi Anemia FANCA-Related Fanconi Anemia FANCC-Related Fanconi Anemia FANCD1-Related Fanconi Anemia FANCD2-Related Fanconi Anemia FANCE-Related Fanconi Anemia FANCF-Related Fanconi Anemia FANCG-Related Fanconi Anemia FANCL-Related Fanconi Anemia FANCA FANCC BRCA2 FANCD2 FANCE FANCF FANCG FANCL 87 Farber Disease ASAH1 FARBER DISEASE 88 FGFR-Related Craniosynostosis Syndromes FGFR1,FGFR2,FGFR3 Apert syndrome FGFR1-Related Craniosynostosis Syndromes Crouzon syndrome Pfeiffer Syndrome Type 1, 2 and 3 Pfeiffer syndrome FGFR2-Related Craniosynostosis Syndromes Apert Syndrome Beare-Stevenson Syndrome Coronal Synostosis Crouzon Syndrome Jackson-Weiss Syndrome Pfeiffer Syndrome Type 1, 2 and 3 FGFR3-Related Craniosynostosis Syndromes Coronal Synostosis Crouzon Syndrome with Acanthosis Nigricans Muenke Syndrome 89 FH-Related Disorders FH FUMARATE HYDRATASE DEFICIENCY Fumarate Hydratase Deficiency 90 Fragile X Syndrome FMR1 Fragile X syndrome X Fragile X-Associated Tremor/Ataxia Syndrome

2 91 Free Sialic Acid Storage Disorders SLC17A5 Salla disases (infantile free sialic acid storage disease) Infantile Free Sialic Acid Storage Disease Salla Disease 92 Fructose 1,6 Bisphosphatase Deficiency FBP1 FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY -1,5-93 GALE Deficiency [Galactose Epimerase Deficiency] GALE GALE DEFICIENCY 94 GALK Deficiency [Galactokinase Deficiency] GALK1 GALK DEFICIENCY 95 GALT Deficiency [Galactosemia] GALT GALT DEFICIENCY Gangliosidosis SANDHOFF DISEASE GM1 Gangliosidosis GLB1 Tay Sachs disease GM2 Gangliosidosis (Hexosaminidase A-Deficient) [Hexosaminidase A Deficiency] HEXA TAY-SACHS DISEASE, AB VARIANT, AB Chronic and Adult-Onset Hexosaminidase A Deficiency Juvenile (Subacute) Hexosaminidase A Deficiency Acute Infantile GM2 Gangliosidosis [Tay-Sachs Disease] GM2 Gangliosidosis (Hexosaminidase A- and B-Deficient) [Sandhoff Disease] GM2 Gangliosidosis, AB Variant [Tay-Sachs Disease, AB Variant][GM2 Activator Deficiency] HEXA,HEXB GM2A 97 Gaucher Disease GBA GAUCHER DISEASE Gaucher Disease Type 1 Gaucher Disease Type 2 (Acute) Gaucher Disease Type 3 (Subacute/Chronic) Gaucher Disease, Cardiovascular Form Gaucher Disease, Perinatal-Lethal Form 98 Glaucoma Glaucoma Glaucoma, Dominant (Adult Onset) OPTN congenital glaucoma Glaucoma, Dominant (Juvenile Onset) Hypoplasia of Iris, with Glaucoma Primary Congenital Glaucoma MYOC PITX2 CYP1B1 99 Glucocorticoid Resistance GR glucocorticoid receptor deficiency 100 Glucose-6-Phosphate Dehydrogenase Deficiency G6PD glucose-6-phosphate dehydrogenase deficiency Glutaricacidemia Type 2 ETFDH GLUTARICACIDURIA IIA IIB IIC IIA IIB IIC 102 Glutathione Synthetase Deficiency [5-Oxoprolinuria] GSS glutathione synthetase deficiency 103 Glycine Encephalopathy GLYCINE ENCEPHALOPATHY (nonketotic hyperglycinemia) AMT-Related Glycine Encephalopathy GCSH-Related Glycine Encephalopathy GLDC-Related Glycine Encephalopathy AMT GCSH GLDC 104 Glycogen Storage Disease GLYCOGEN STORAGE DISEASE Ia 1a Glycogen Storage Disease Type 1a G6PC GLYCOGEN STORAGE DISEASE Ib 1b Glycogen Storage Disease Type 1b SLC37A4 GLYCOGEN STORAGE DISEASE II 2 Glycogen Storage Disease Type II GAA GLYCOGEN STORAGE DISEASE III 3 Glycogen Storage Disease Type IIb LAMP2 GLYCOGEN STORAGE DISEASE IV 4 Glycogen Storage Disease Type III AGL GLYCOGEN STORAGE DISEASE V 5 Glycogen Storage Disease Type IV GBE1 GLYCOGEN STORAGE DISEASE VI 6 Glycogen Storage Disease Type V PYGM GLYCOGEN STORAGE DISEASE VII 7 Glycogen Storage Disease Type VI Glycogen Storage Disease Type VII [Phosphofructokinase (MUSCLE TYPE) Deficiency] Glycogen Storage Disease Type IX PYGL PFKM PHKA2 105 Granular Corneal Dystrophy TGFB1(=BIGH3) granularcornealdystrophy GroenouwtypeI 106 Guanidinoacetate Methyltransferase Deficiency GAMT guanidinoacetate methyltransferase deficiency 107 Hemochromatosis HFE ideopathic hemochromatosis - HFE- Associated Hereditary Hemochromatosis Juvenile Hereditary Hemochromatosis HAMP-Related Juvenile Hereditary Hemochromatosis HFE2-Related Juvenile Hereditary Hemochromatosis Neonatal Hemochromatosis SLC40A1-Related Hereditary Hemochromatosis TFR2-Related Hereditary Hemochromatosis 108 Hemophilia Hemophilia A A Hemophilia A F8 Hemophilia B B Hemophilia B F9 109 Hereditary Angioneurotic Edema SERPING1 Hereditary angioneurotic edema 110 Hereditary Fructose Intolerance ALDOB FRUCTOSE INTOLERANCE, HEREDITARY 111 Hereditary Non-Polyposis Colon Cancer MLH1,MLH2,MLH6,PMS2 hereditary nonpolyposis colorectal cancer (HNPCC) Muir-Torre Syndrome Adenomatous Polyposis Coli with CNS Tumors [Turcot Syndrome] 112 Hereditary Spastic Paraplegia Hereditary Spastic Paraplegia

3 Spastic Paraplegia, Type 1 Spastic Paraplegia, Type 2 Spastic Paraplegia, Type 3 Spastic Paraplegia, Type 4 Spastic Paraplegia, Type 6 Spastic Paraplegia, Type 7 Spastic Paraplegia, Type 13 Spastic Paraplegia, Type 20 L1CAM PLP1 SPG3A SPG4 NIPA1 SPG7 HSPD1 SPG Hermansky-Pudlak Syndrome Hermansky-Pudlak syndrome Hermansky-Pudlak Syndrome 1 Hermansky-Pudlak Syndrome 2 Hermansky-Pudlak Syndrome 3 Hermansky-Pudlak Syndrome 4 Hermansky-Pudlak Syndrome 5 Hermansky-Pudlak Syndrome 6 Hermansky-Pudlak Syndrome 7 HPS1 AP3B1 HPS3 HPS4 HPS5 HPS6 DTNBP1 114 Holoprosencephaly holoprosencephaly Holoprosencephaly 1 Holoprosencephaly 2 Holoprosencephaly 3 Holoprosencephaly 4 Holoprosencephaly 5 Holoprosencephaly 7 TMEM1 SIX3 SHH TGIF ZIC2 PTCH 115 Holt-Oram Syndrome TBX5 Holt-Oram syndrom 116 Homocystinuria Homocystinuria Homocystinuria (MTHFR Deficiency) [MTHFR Deficiency ] MTHFR HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY MTHFR Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency CBS HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA Homocystinuria-Megaloblastic Anemia MTRR 117 Huntington Disease HD HUNTINGTON CHOREA 253 Hyper IgD Syndrome MVK Hyper-IgD syndrome IgD 118 Hyper IgM Syndrome Hyper-IgM syndrome IgM Immunodeficiency with Hyper-IgM, Type 2 Immunodeficiency with Hyper-IgM, Type 3 Immunodeficiency with Hyper-IgM, Type 5 X-Linked Hyper IgM Syndrome HIGM2(AICDA) CD40(TNFRSF5) HIGM5 UNG HIGM1 TNFSF5 119 Hyperaldosteronism CYP11B1,CYP11B2 GRA Familial Hyperaldosteronism Type 1 [Glucocorticoid-Remediable Aldosteronism ] 120 Hyperbilirubinemia Constitutional hyperbilirubinemia Hyperbilirubinemia Type I [Gilbert Syndrome] Hyperbilirubinemia Type II [Dubin-Johnson Syndrome] UGT1A1 ABCC2(=CMORT1) 121 Hyperlipoproteinemia HYPERLIPOPROTEINEMIA, TYPE I LpL deficiency I LpL Type I Hyperlipoproteinemia [Familial Lipoprotein Lipase Deficiency] Familial Hypercholesterolemias Hyperlipoproteinemia Type IIA [Familial Hypercholesterolemia] Familial Hypercholesterolemia Type B Hyperlipoproteinemia Type III LPL LDLR APOB APOE 122 Hyperlysinemia AASS HYPERLYSINEMIA 123 Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrom SLC25A15 hyperornithinema-hypoerammonemia-homocitrullinuria syndrome Hyperoxaluria, Primary HYPEROXALURIA, PRIMARY, TYPE I I Hyperoxaluria, Primary, Type 1 AGXT HYPEROXALURIA, PRIMARY, TYPE II II Hyperoxaluria, Primary, Type 2 GRHPR 125 Hyperprolinemia HYPERPROLINEMIA, TYPE II II Hyperprolinemia, Type I Hyperprolinemia, Type II PRODH ALDH4A1 126 Hypogonadotropic Hypogonadism Kallmann syndrome Kallmann Syndrome, X-Linked KAL1 127 Hypophosphatasia ALPL HYPOPHOSPHATASIA, INFANTILE 128 Hypothyroidism HYPOTHYROIDISM, CONGENITAL, DUE TO THYROID DYSGENESIS Congenital Hypothyroidism Hypothyroidism, Athyroidal, with Spiky Hair and Cleft Palate [Bamforth-Lazarus Syndrome] FOXE1,PAX8,TSHR FOXE1 129 Ichthyosis ichthyosis Autosomal Recessive Congenital Ichthyosis ABCA12-Related Autosomal Recessive Congenital Ichthyosis ALOX12B-Related Autosomal Recessive Congenital Ichthyosis ALOXE3-Related Autosomal Recessive Congenital Ichthyosis ABCA12 ALOX12B ALOXE3

4 TGM1-Related Autosomal Recessive Congenital Ichthyosis Ichthyosis Bullosa of Siemens Ichthyosis, X-Linked Keratitis-Ichthyosis-Deafness Syndrome, Autosomal Dominant TGM1 KRT2A STS GJB2 130 Incontinentia Pigmenti IKBKG incontinentia pigmenti 131 Keratosis keratosis Dyskeratosis Congenita [Zinsser-Cole-Engman Syndrome] TERC,DKC1 Zinsser-Cole-Engman syndrome - - Epidermolytic Hyperkeratosis Hereditary Mucosal Leukokeratosis [White Sponge Nevus of Cannon] Keratosis Follicularis [Darier Disease] Keratosis Palmoplantaris with Arrhythmogenic Cardiomyopathy [Naxos Disease] Keratosis Palmoplantaris with Corneal Dystrophy [Tyrosinemia Type II] Localized Epidermolytic Hyperkeratosis [Epidermolytic Palmoplantar Keratoderma] Nonepidermolytic Palmoplantar Hyperkeratosis KRT1,KRT10 KRT13,KRT4 ATP2A2 JUP TAT KRT9 KRT1,KRT Krabbe Disease GALC KRABBE DISEASE 133 L1 Syndrome L1CAM HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT X MASA Syndrome Spastic Paraplegia, Type 1 X-Linked Corpus Callosum Agenesis X-Linked Hydrocephalus with Stenosis of the Aqueduct of Sylvius 134 Langer-Giedion Syndrome LGCR Langer-Giedion syndrome 135 LCAT Deficiency [Lecithin Cholesterol Acyltransferase Deficiency] LCAT LCAT DEFICIENCY LCAT 136 Leber Congenital Amaurosis RPE65.GUCY2D,AIPL1,RPGRIP1,CRB1,CRX Leber s congenital amaurosis 137 Lesch-Nyhan Syndrome HPRT1 LESCH-NYHAN SYNDROME 138 Leukoencephalopathy Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts OF SYLVIUS Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and NOTCH3 and Leukoencephalopathy Leukoencephalopathy [CADASIL] Cree Leukoencephalopathy EIF2B5 Leukodystrophy with vanishing white matter Leukoencephalopathy with Vanishing White Matter [Childhood Ataxia with Central EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5 Megalencephalic Leukodystorophy with subcortical cysts Nervous System Hypomyelination/Vanishing White Matter] Megalencephalic Leukoencephalopathy with Subcortical Cysts Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy [PLOSL] MLC1 TYROBP,TREM2 139 Li-Fraumeni Syndrome TP53,CHEK2 Li-Fraumeni Syndrome Limb-Girdle Muscular Dystrophy distal myopathy Limb-Girdle Muscular Dystrophies, Autosomal Dominant TTID,CAV3,COL6A1,COL6A2,COL6A3,LMNA limb-girdle muscular dystrophy Caveolinopathy LGMD1A LGMD1B LGMD1D LGMD1E Limb-Girdle Muscular Dystrophies, Autosomal Recessive Calpainopathy Dysferlinopathy LGMD2H LGMD2I Limb Girdle Muscular Dystrophy Type 2B Miyoshi Distal Myopathy Sarcoglycanopathies Alpha-Sarcoglycanopathy Beta-Sarcoglycanopathy Delta-Sarcoglycanopathy Gamma-Sarcoglycanopathy Telethoninopathy DYSF,CAPN3,SGCG,SGCA,SGCB,SGCD,TCAP,TRIM32,FKRP 141 LIS1-Associated Lissencephaly/Subcortical Band Heterotopia LIS1 Miller-Dieker lissencephaly syndrome - 17-Linked Subcortical Band Heterotopia Isolated 17-Linked Lissencephaly Miller-Dieker Syndrome 142 Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency HADHA,HADHB LONG-CHAIN HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY -CoA 143 Long QT Syndrome long QT syndrome QT Long QT Syndrome 7 [Andersen Syndrome] KCNJ2 Romano-Ward syndrome LQT1 - LQT1 Andersen Syndrome Type 1 Romano-Ward syndrome LQT2 - LQT2 Andersen Syndrome Type 2 Romano-Ward syndrome LQT3 - LQT3 Long QT Syndrome, Autosomal Dominant [Romano-Ward Syndrome] Romano-Ward syndrome LQT5 - LQT5 LQT 1 LQT 2 KCNQ1 KCNH2

5 LQT 3 LQT 4 LQT 5 LQT 6 Long QT Syndrome, Autosomal Recessive [Jervell and Lange-Nielsen Syndrome] LQT 1 LQT 5 SCN5A ANK2 KCNE1 KCNE2 KCNQ1 KCNE1 144 Lowe Syndrome OCRL Lowe syndrome 145 Lymphoproliferative Disease, X-Linked SH2D1A X-linked lymphoproliferative syndrome 146 Lysinuric Protein Intolerance SLC7A7 lysinuric protein intorelanse 147 Malonyl-CoA Decarboxylase Deficiency MLYCD MALONYL-CoA DECARBOXYLASE DEFICIENCY -CoA 148 Marfan Syndrome FBN1 Marfan syndrome Marfan Syndrome Marfan Syndrome II 149 May-Hegglin Anomaly MYH9 May-Hegglin anomaly 150 McCune-Albright Syndrome [Albright Hereditary Osteodystrophy] GNAS McCune-Albright Syndrome (Albright hereditary osteodystrophy), (Pseudohypoparathyroidism) pseudohypoparathyroidism 151 Megaloblastic Anemia megaloblastic anemia Homocystinuria-Megaloblastic Anemia Thiamine-Responsive Megaloblastic Anemia Syndrome MTRR SLC19A2 152 Metachromatic Leukodystrophy ARSA,PSAP METACHROMATIC LEUKODYSTROPHY 153 Methionine Adenosyltransferase Deficiency [Isolated Persistent Hypermethioninemia] MAT1A METHIONINE ADENOSYLTRANSFERASE DEFICIENCY 154 Mevalonate Kinase Deficiency [Mevalonicaciduria] MVK MEVALONATE KINASE DEFICIENCY 155 Mitochondrial Disorders mitochondrial DNA aminoglycoside-induced deafness/non-syndromic deafness / Chorea and Dementia chronic progressive ophthalmoplgia Diabetes and Hearing Loss Kearns-Sayre syndrome Infantile Myopathy and Lactic Acidosis (Fatal and Non-Fatal Forms) Leber hereditary optic neuropathy Leber Hereditary Optic Neuropathy MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC MELAS MELAS ACIDOSIS, AND STROKELIKE EPISODES:MELAS(=MIDD) MERRF MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS MERRF Mitochondrial DNA Deletion Syndromes Pearson's marrow-pancreas syndrome (PMPS) Kearns-Sayre Syndrome Pearson Syndrome Progressive External Ophthalmoplegia Mitochondrial DNA-Associated Leigh Syndrome and NARP Nonsyndromic Hearing Loss and Deafness, Mitochondrial MTRNR1-Related Hearing Loss and Deafness MTTS1-Related Hearing Loss and Deafness 156 Mucolipidosis mucolipidosis Mucolipidosis I Mucolipidosis II Mucolipidosis IV NEU1 GNPTA MCOLN1 157 Mucopolysaccharidosis MUCOPOLYSACCHARIDOSIS TYPE 1 Mucopolysaccharidosis Type I IDUA MUCOPOLYSACCHARIDOSIS TYPE 2 Hurler Syndrome MUCOPOLYSACCHARIDOSIS TYPE 3-A 3A Hurler-Scheie Syndrome MUCOPOLYSACCHARIDOSIS TYPE 3-A 3D Mucopolysaccharidosis Type II IDS MUCOPOLYSACCHARIDOSIS TYPE 3-B 3B Mucopolysaccharidosis Type IIIA SGSH MUCOPOLYSACCHARIDOSIS TYPE 4-D 4A Mucopolysaccharidosis Type IIIB NAGLU MUCOPOLYSACCHARIDOSIS TYPE 5 Mucopolysaccharidosis Type IIID GNS MUCOPOLYSACCHARIDOSIS TYPE 6 Mucopolysaccharidosis Type IVA Mucopolysaccharidosis Type IVB Mucopolysaccharidosis Type VI Mucopolysaccharidosis Type VII GALNS GLB1 ARSB GUSB 158 Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia type 1 1 Multiple Endocrine Neoplasia Type 1 MEN1 Multiple Endocrine Neoplasia type 2A, B 2 A, B Multiple Endocrine Neoplasia Type 2 Familial Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2B RET 159 Multiple Epiphyseal Dysplasia multiple epiphyseal dysplasia Multiple Epiphyseal Dysplasia, Dominant COL9A1-Related Multiple Epiphyseal Dysplasia COL9A2-Relarted Multiple Epiphyseal Dysplasia COL9A3-Related Multiple Epiphyseal Dysplasia COL9A1 COL9A2 COL9A3

6 COMP-Related Multiple Epiphyseal Dysplasia MATN3-Related Multiple Epiphyseal Dysplasia Multiple Epiphyseal Dysplasia, Recessive COMP MATN3 SLC6A2 160 Myoadenylate Deaminase Deficiency [Adenosine Monophosphate Deaminase 1] AMPD1 ADENOSINE MONOPHOSPHATE DEAMINASE 1DEFICIENSY I 161 Myoclonic Epilepsy familial progressive myoclonic epilepsy syndrome Myoclonic Epilepsy of Lafora Progressive Myoclonic Epilepsy 2A Progressive Myoclonic Epilepsy 2B Myoclonic Epilepsy of Unverricht and Lundborg [Unverricht-Lundborg Disease] EPM2A NHLRC1 CSTB 162 Myoclonus-Dystonia SGCE familial myoclonus 163 Myotonic Dystrophy MYOTONIC DYSTROPHY Myotonic Dystrophy Type 1 Myotonic Dystrophy Type 2 DMPK ZNF9

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

All diseases on Foresight

All diseases on Foresight All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

PREDICAGEN LLC REPORT

PREDICAGEN LLC REPORT The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because

More information

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

More information

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5 Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) (Formerly Genetic Testing for Inherited Disorders) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization Yes Review Dates:

More information

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function 1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency

More information

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) Medical Benefit Effective Date: 01/01/17 Next Review Date: 11/18 Preauthorization Yes Review Dates: 01/11, 01/12, 09/12, 05/13, 09/13, 09/14, 09/15,

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies

More information

Presentation and investigation of mitochondrial disease in children

Presentation and investigation of mitochondrial disease in children Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product

More information

PGD: A Celebration of 20 years:

PGD: A Celebration of 20 years: PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,

More information

Genetic Diseases. SCPA202: Basic Pathology

Genetic Diseases. SCPA202: Basic Pathology Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities

More information

Residual risks by ethnicity

Residual risks by ethnicity Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel

More information

Foresight Carrier Screen

Foresight Carrier Screen Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:

More information

Standard Therapies - Cord Blood

Standard Therapies - Cord Blood A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical

More information

Utility of Microarrays in Molecular Genetics

Utility of Microarrays in Molecular Genetics Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,

More information

Reproducibility with zebrafish models of human health and disease

Reproducibility with zebrafish models of human health and disease Reproducibility with zebrafish models of human health and disease Monte Westerfield, University of Oregon, Eugene, USA Sponsored by the Office of the Director National Institutes of Health, the National

More information

CARRIER SCREEN - LIST OF DISORDERS

CARRIER SCREEN - LIST OF DISORDERS 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:

More information

FABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease

FABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease Ophthalmologic Signs of Genetic Neurological Disease ES ROACH,MD. Ophthalmologic Signs of Genetic Neurological Disease Conjunctival lesions Corneal lesions Lesions of iris & lens Retinal vascular lesions

More information

Draw a pedigree during the neurological consultation

Draw a pedigree during the neurological consultation 38 PRACTICAL NEUROLOGY HOW TO DO IT Draw a pedigree during the neurological consultation Saif S.M. Razvi* and Ian Bone *Specialist Registrar and Professor of Neurology, Division of Clinical Neurosciences,

More information

Original Policy Date

Original Policy Date MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

Informed Consent Columbia Whole Genome or Whole Exome Sequencing

Informed Consent Columbia Whole Genome or Whole Exome Sequencing Informed Consent Columbia Whole Genome or Whole Exome Sequencing Please read the following form carefully and discuss with your ordering physician before signing consent. This consent is intended for the

More information

What s New in Newborn Screening?

What s New in Newborn Screening? What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of

More information

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR

More information

Evolve FamilyReady Carrier Screen

Evolve FamilyReady Carrier Screen Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy

More information

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First #: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered

More information

Centers for Medicare and Medicaid Services

Centers for Medicare and Medicaid Services Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule Annual Laboratory Public Meeting June 25, 2018 Anthony Sireci, MD, Msc Association for Molecular Pathology Outline Germline Procedures

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

EURORDIS Member Organisations - Diseases - ERN Groupings Working Document

EURORDIS Member Organisations - Diseases - ERN Groupings Working Document EURORDIS Member Organisations - Diseases - ERN Groupings Working Document Diseases ERN Group - Primary ERN Group - secondary Achondroplasia Fibrodysplasia ossificans progressiva Fibrous dysplasia of bone

More information

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) DEFICIENCY OF METABOLITE -HYPOXIA AND HYPOGLYCEMIA -HYPOVITAMINOSIS SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) -SPECIFIC CELL TYPE NEURONS>OLIGODENDROCYTES>ASTROCYTES -SPECIFIC BRAIN REGION PYRAMIDAL

More information

Lab Prior Authorization

Lab Prior Authorization Lab Prior Authorization On July 22, 2015, BlueCross BlueShield of South Carolina announced that it will partner with Avalon Healthcare Solutions (Avalon) to administer a comprehensive suite of laboratory

More information

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s) CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact

More information

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance Mendelian pedigree patterns Autosomal-dominant inheritance Autosomal dominant Autosomal recessive X-linked dominant X-linked recessive Y-linked Examples of AD inheritance Autosomal-recessive inheritance

More information

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017 Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml

More information

CLINICAL AND HUMAN TESTING

CLINICAL AND HUMAN TESTING CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with

More information

Strand Neuromuscular Disorders Test: Genes & Test Selection

Strand Neuromuscular Disorders Test: Genes & Test Selection 1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection

More information

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016. CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to

More information

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search

More information

CARRIER SCREENING PANEL

CARRIER SCREENING PANEL 1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance

More information

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No

More information

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type)

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type) Blood and Clotting Coagulation factor VII deficiency Elliptocytosis Hemophilia A (German Shepherd Dog, type 2) Pyruvate kinase deficiency (Labrador Retriever type) Thrombopathia (American Eskimo Dog type)

More information

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary Results Recipient University Medical Center 827 Attn: Dr. Paul Smith 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 NPI: 7834324983 Report Date: 09/09/2013 Female Ethnicity:

More information

cataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID

cataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID versie 16-Apr-2018 (63 genen) cataract panel Centrum voor Medische Genetica Gent Gene OMIM gene ID AGK 610345 ALDH18A1 138250 Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance

More information

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome Report Date: August 2, 215 Software Annotation Version: 8 Genome Summary Name: Greg Mendel Genome ID: genome_greg_mendel_dad Sequencing Provider: 23andMe Sequencing Type: Genotyping SNP Array Sequencing

More information

The Prior Authorization List 2017

The Prior Authorization List 2017 ADVANCING CLINICALLY APPROPRIATE LAB TECHNOLOGY AND SERVICES The Prior Authorization List 2017 Revised April 12, 2017 Visit us at Avalonhcs.com BlueCross BlueShield of South Carolina is an independent

More information

FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY # Colorectal cancer, hereditary nonpolyposis # Meckel syndrome, type 1 #249000

FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY # Colorectal cancer, hereditary nonpolyposis # Meckel syndrome, type 1 #249000 Supplementary Table 1 A randomly selected subset of 100 record pairs crossreferenced by the curators. To be sure the 7,000 cross referenced records in fact were pairs of highly overlapping phenotypes,

More information

Beyond Mendel s Laws of Inheritance

Beyond Mendel s Laws of Inheritance Beyond Mendel s Laws of Inheritance 2006-2007 Extending Mendelian genetics Mendel worked with a simple system peas are genetically simple most traits are controlled by a single gene each gene has only

More information

An Introduction to mitochondrial disease.

An Introduction to mitochondrial disease. 9 th September 2017 An Introduction to mitochondrial disease. Dr Andy Schaefer Consultant Neurologist and Clinical Lead NHS Highly Specialised Rare Mitochondrial Disease Service and Wellcome Trust Centre

More information

MAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID

MAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID versie 16-Apr-2018 (59 genen) MAC-ASD panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCB6 605452 [Blood

More information

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy

More information

Results for Trendy. Explanation of Results

Results for Trendy. Explanation of Results Canine HealthCheck Results for Trendy Trendy's genetic health profile: Trendy's appearance profile: Trendy is not at-risk for any of the diseases tested Trendy is a Female Trendy is not a carrier for any

More information

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN Genomics and Genetics in Healthcare By Mary Knutson, RN, MSN Clinical Objectives Understand the importance of genomics to provide effective nursing care Integrate genetic knowledge and skills into nursing

More information

NYEIS Version 4.3 (ICD) ICD - 10 Codes Available in NYEIS at time of version launch (9/23/2015)

NYEIS Version 4.3 (ICD) ICD - 10 Codes Available in NYEIS at time of version launch (9/23/2015) D82.1 Di George's syndrome E63.9 Nutritional deficiency, unspecified E70.21 Tyrosinemia E70.29 Other disorders of tyrosine metabolism E70.30 Albinism, unspecified E70.5 Disorders of tryptophan metabolism

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing

More information

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays TECHNICAL NOTICE The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays December 2012 The notation (MAAA) indicates "Multianalyte Assay with

More information

Basic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH

Basic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH Basic Definitions Chromosomes There are two types of chromosomes: autosomes (1-22) and sex chromosomes (X & Y). Humans are composed of two groups of cells: Gametes. Ova and sperm cells, which are haploid,

More information

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8 MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:

More information

What s New in Newborn Screening?

What s New in Newborn Screening? What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is administered by the Illinois Department of Public Health.

More information

MITOCHONDRIAL DISEASE. Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital

MITOCHONDRIAL DISEASE. Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital MITOCHONDRIAL DISEASE Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital Disclosures & Disclaimers United Mitochondrial Disease Foundation Research Grant North American Mitochondrial

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust, Level 1, The Women s Centre John Radcliffe Hospital University Hospitals NHS Foundation Trust OX3

More information

COMPLETE LIST OF GENETIC ANALYSES

COMPLETE LIST OF GENETIC ANALYSES Aarskog-Scott syndrome Achondroplasia Achromatopsia Acromesomelic dysplasia, Maroteaux type Adenosine deaminase deficiency Adrenoleukodystrophy Aicardi-Goutieres syndrome Alagille syndrome Albinism Alkaptonuria

More information

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15

More information

Genetic Testing for Non-Cancerous Inheritable Diseases

Genetic Testing for Non-Cancerous Inheritable Diseases Genetic Testing for Non-Cancerous Inheritable Diseases Policy Number: Original Effective Date: MM.02.009 03/01/2010 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2013 Section: Medicine

More information

Results Recipient Ordering Healthcare Professional Male Details Female Details

Results Recipient Ordering Healthcare Professional Male Details Female Details Results Recipient Ordering Healthcare Professional Male Details Details Report Date /2010 Attn: Jessica Jacobson, MD Counsyl, Inc. 2200 Bridge Parkway, Suite 103 Redwood City, CA 94065 Phone: 1-888-COUNSYL

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

A rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband

A rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband A rare case of muscular dystrophy with POMT2 and FKRP gene mutation Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband Index : Congenital muscular dystrophy (CMD) Dystroglycanopathies Walker-Warburg

More information

Results for Dar. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Dar. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Dar Dar's demographic profile: Call Name: Dar Registered Name: Newman's Allendar of Lost Acres Breed: Collie Sex: Male Age: 0 Owner: Registration #: DN47650805 Microchip/Tattoo:

More information

GABE. Customer-supplied information. Genetic summary. Karyogram (Chromosome painting) Genetic Vet Report by. embarkvet.com

GABE. Customer-supplied information. Genetic summary. Karyogram (Chromosome painting) Genetic Vet Report by. embarkvet.com GABE Genetic Vet Report by embarkvet.com Customer-supplied information Owner Name: Nightside Nordics Dog Name: Gabe Sex: Male (intact) Date of birth: 01/01/08 Breed type: mixed Breed: n/a Breed registration:

More information

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Diagnose a broad range of metabolic disorders with a single test, Global MAPS PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds

More information

Fatty Acids Synthesis L3

Fatty Acids Synthesis L3 Fatty Acids Synthesis L3 The pathway for fatty acid synthesis occurs in the cytoplasm, whereas, oxidation occurs in the mitochondria. The other major difference is the use of nucleotide co-factors. Oxidation

More information

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child

More information

Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy Limb Girdle Muscular Dystrophy Reza Shervin Badv MD, Pediatric Neurologist Children s Medical Center Pediatrics Center of Excellence Tehran University of Medical Sciences Limb-girdle muscular dystrophies(lgmd)

More information

Genetic Testing for Inherited Conditions

Genetic Testing for Inherited Conditions Genetic Testing for Inherited Conditions Policy Number: 2018-101 Effective Date: January 26, 2018 Review Date: January 26, 2018 Next Review Date: January 26, 2019 Important Information - Please Read Before

More information

Reproductive Physiology Primordial Germ Cells Yolk Sac Sex Chromosomes Females Males Sex-Linked Traits

Reproductive Physiology Primordial Germ Cells Yolk Sac Sex Chromosomes Females Males Sex-Linked Traits Reproductive Physiology Primordial Germ Cells - from Yolk Sac these migrate to fetus when it is 5 weeks old - these cells give rise to the gonads (ovaries for female, testes for male) first they form the

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY GNA FOP Familial Adenomatous Polyposis Beckwith-Wiedemann Syndrome Methylation and high resolution copy number analysis of 11p15.5 with automatic reflex to CDKN1C if negative Methylation analysis of 11p15.5

More information

Clinical Approach to Diagnosis of Lysosomal Storage Diseases

Clinical Approach to Diagnosis of Lysosomal Storage Diseases Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders

More information

C-type: For each numbered item or question, indicate whether it is associated

C-type: For each numbered item or question, indicate whether it is associated C-type: For each numbered item or question, indicate whether it is associated with: (A) A only (B) B only (C) Both A and B (D) Neither A nor B ( ) 1. About neuroleptic malignant syndrome and serotonin

More information

Whole Exome Sequencing (WES): Questions and Answers for Providers

Whole Exome Sequencing (WES): Questions and Answers for Providers Whole Exome Sequencing (WES): Questions and Answers for Providers 1. What is Whole Exome Sequencing?... 2 2. What is the difference between Whole Exome Sequencing (WES) and Whole Exome Sequencing Plus

More information

Results for Ceaser. Em Locus (Melanistic Mask) Explanation of Results

Results for Ceaser. Em Locus (Melanistic Mask) Explanation of Results Results for Ceaser Ceaser's demographic profile:!"## $"%&'!&"(&) *&+,(-&)&. $"%&' /000000 1)&&.' 12##.3+ /&0' 4"#& 566)307 891' :;;?!"#$%&'''''''!"#$%&'(&$)* +, -./4567 0$1')12$345(&&)),!"# $% &'&((((

More information

Section VI. Rare and Expensive Case Management (REM) Program

Section VI. Rare and Expensive Case Management (REM) Program Section VI Rare and Expensive Case Management (REM) Program OVERVIEW The Department of Health and Mental Hygiene (DHMH) administers a Rare and Expensive Case Management (REM) program to address the special

More information

Genetic Testing for Non-Cancerous Inheritable Diseases

Genetic Testing for Non-Cancerous Inheritable Diseases Genetic Testing for Non-Cancerous Inheritable Diseases Policy Number: Original Effective Date: MM.02.009 03/01/2010 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2016 Section:

More information

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD April 24, 2017 SAP 2017 Buenos Aires Genetic disorders are rare why

More information

Results for Diva. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Diva. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Diva Diva's demographic profile: Call Name: Diva Registered Name: Rus Pekos Diva Chudo Prirody Breed: Golden Retriever Sex: Female Approx. DOB: 2016-07 Owner: Registration

More information

Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis

Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis Katie Bainbridge Enzyme Laboratory Great Ormond Street Hospital Glycogen Metabolism Glycogen Glycogen -glucosidase Lysosome Brancher Glycogen

More information